HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NPA Pre-DSHEA Ingredients Book: First Chapter In FDA's Industry-Sourced Reading?

This article was originally published in The Rose Sheet

Executive Summary

NPA published a book listing pre-DSHEA dietary ingredients and FDA is interested in reviewing the trade group's methodology for compiling the list, which could be a litmus test for how the agency will evaluate industry-produced lists of “old” ingredients.

You may also be interested in...



NPA Submits Wish List For Reducing FDA Regulatory Burdens Per Trump Order

FDA’s NDI notification draft guidance should be rewritten and its Nutrition Facts and Supplement Facts Final Rule delayed, the Natural Products Association says in comments submitted to the agency in response to President Trump’s executive order aimed at cutting down on burdensome regulations.

FDA Expects Safety As Ticket To Enter 'Pre-DSHEA' Dietary Ingredient List

FDA agrees with public health advocates that ingredients should be on a potential list of those available when Congress passed DSHEA only after current substantiation for a reasonable expectation of safety for their intended uses.

Revised NDI Notification Draft Guidance Shrinks Divide Between FDA And Industry

More than four years after beginning to revise its widely criticized initial draft guidance on NDI notifications, FDA on Aug. 11 released a second draft. "I think it is reflective of a new effort by the agency to have a dialogue with the industry," says Steve Mister, president and CEO of the Council for Responsible Nutrition.

Topics

UsernamePublicRestriction

Register

RS121310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel